account_id none on file
legal_name Prothena Corp Public Ltd Co
ticker PRTA
cik 1559053
domain prothena.com
linkedin_company_url https://www.linkedin.com/company/prothena_biosciences_inc/
entry_point_account_id none on file
name Prothena Corporation plc
exchange Nasdaq
sector Health Care
hq Dublin 2, Ireland
sector index/company/sector/health-care/
calls 0 filings 12 executives 6 family 0
why_nownone on file
callsnone on file
filings
Our contractual obligations as of June 30, 2026, consisted of minimum cash payments under operating leases of $7.5 million , purchase obligations of $1.6 million (of which $0.2 million is included in current liabilities), cash obligations under our restructuring plan of $0.3 million (of which all of it is included in current liabilities), and contractual obligations under license agreements of $35,000.
filing / Aug 6, 2026 / receipt
Obligations under the restructuring plan (3) 349 349 - - - - - Contractual obligations under license agreements 35 20 15 - - - - Total $ 9,446 $ 3,593 $ 3,330 $ 2,523 $ - $ - $ - (1) See Note 6, “ Commitments and Contingencies ” to our Condensed Consolidated Financial Statements.
filing / Aug 6, 2026 / receipt
In June 2021, we entered into a lease agreement for office space in Dublin, Ireland, which commenced in August 2021 and had an initial term of one year.
filing / Aug 6, 2026 / receipt
In addition, we entered into a lease agreement for additional office space in Dublin, Ireland, which commenced in August 2023 and had an initial term of one year.
filing / Aug 6, 2026 / receipt
Furthermore, any governmental or business actions, or any actions taken by individuals in response to any such events (including mandatory quarantines, travel restrictions, delay in operations of the U.S.
filing / Aug 6, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our drugs.
filing / Aug 6, 2026 / receipt
Our contractual obligations as of March 31, 2026, consisted of minimum cash payments under operating leases of $8.3 million, purchase obligations of $2.3 million (of which $2.0 million is included in current liabilities), cash obligations under our restructuring plan of $8.6 million (of which all of it is included in current liabilities), and contractual obligations under license agreements of $35,000.
filing / May 7, 2026 / receipt
Obligations under the restructuring plan (3) 8,585 8,585 - - - - - Contractual obligations under license agreements 35 20 15 - - - - Total $ 19,217 $ 13,410 $ 3,284 $ 2,523 $ - $ - $ - (1) See Note 6, “ Commitments and Contingencies ” to our Condensed Consolidated Financial Statements.
filing / May 7, 2026 / receipt
In June 2021, we entered into a lease agreement for office space in Dublin, Ireland, which commenced in August 2021 and had an initial term of one year.
filing / May 7, 2026 / receipt
In addition, we entered into a lease agreement for additional office space in Dublin, Ireland, which commenced in August 2023 and had an initial term of one year.
filing / May 7, 2026 / receipt
Furthermore, any governmental or business actions, or any actions taken by individuals in response to any such events (including mandatory quarantines, travel restrictions, delay in operations of the U.S.
filing / May 7, 2026 / receipt
The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our drugs.
filing / May 7, 2026 / receipt
executives
| Daniel G. Welch | director | - | receipt |
| Helen S. Kim | director | - | receipt |
| Martin Koller | Chief Medical Officer | - | receipt |
| Oleg Nodelman | director | - | receipt |
| Paula K. Cobb | director | - | receipt |
| Tran B. Nguyen | Chief Operating Officer | - | receipt |
familynone on file
upcoming
| 2026-11-05 | earnings call | scheduled | ir |
changes
| 2024-02-21 | director, appointed | sec_8k |
| 2022-09-01 | director, appointed | sec_8k |
| 2019-12-05 | director, appointed | sec_8k |
| 2019-07-03 | director, appointed | sec_8k |
| 2018-06-25 | Chief Operating Officer, appointed | sec_8k |
| 2013-03-28 | Chief Financial Officer, appointed | sec_8k |
| 2013-03-28 | Chief Medical Officer, appointed | sec_8k |
mcp_package_hint
slug prothena-corporation-plc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$